Skip to main content

Main menu

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • COVID-19 and Rheumatology
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Author Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • GDPR Policy
    • Accessibility
  • Contact Us
  • JRheum Supplements
  • Services

User menu

  • My Cart
  • Log In

Search

  • Advanced search
The Journal of Rheumatology
  • JRheum Supplements
  • Services
  • My Cart
  • Log In
The Journal of Rheumatology

Advanced Search

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • COVID-19 and Rheumatology
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Author Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • GDPR Policy
    • Accessibility
  • Contact Us
  • Follow jrheum on Twitter
  • Visit jrheum on Facebook
  • Follow jrheum on LinkedIn
  • Follow jrheum on RSS
LetterCorrespondence

Indirect Evidence for the Efficacy of Methotrexate in Diffuse Systemic Sclerosis

ANDREA H.L. LOW and PETER LEE
The Journal of Rheumatology November 2008, 35 (11) 2286; DOI: https://doi.org/10.3899/jrheum.080492
ANDREA H.L. LOW
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
PETER LEE
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • References
  • Info & Metrics
  • PDF
  • eLetters
PreviousNext
Loading

Excerpt

To the Editor:

The use of methotrexate (MTX) in the treatment of systemic sclerosis (SSc) remains controversial. We provide indirect evidence for the efficacy of MTX in 3 patients with diffuse SSc who had good response of skin scores to MTX, significant worsening after stopping MTX, and subsequent improvement with reinstitution of MTX.

Patients were 39 to 51 years old at reported onset of skin thickening. The initial modified Rodnan skin scores (mRSS) were all ≥ 20. All patients had Raynaud’s phenomenon and joint and gastrointestinal (GI) manifestations.

Patient 1 was positive for antinuclear antibody (ANA, speckled), but negative for ...

Footnotes

    PreviousNext
    Back to top

    In this issue

    The Journal of Rheumatology
    Vol. 35, Issue 11
    1 Nov 2008
    • Table of Contents
    • Index by Author
    Download PDF
    Article Alerts
    Sign In to Email Alerts with your Email Address
    Email Article

    Thank you for your interest in spreading the word about The Journal of Rheumatology.

    NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

    Enter multiple addresses on separate lines or separate them with commas.
    Indirect Evidence for the Efficacy of Methotrexate in Diffuse Systemic Sclerosis
    (Your Name) has forwarded a page to you from The Journal of Rheumatology
    (Your Name) thought you would like to see this page from the The Journal of Rheumatology web site.
    CAPTCHA
    This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
    Citation Tools
    Indirect Evidence for the Efficacy of Methotrexate in Diffuse Systemic Sclerosis
    ANDREA H.L. LOW, PETER LEE
    The Journal of Rheumatology Nov 2008, 35 (11) 2286; DOI: 10.3899/jrheum.080492

    Citation Manager Formats

    • BibTeX
    • Bookends
    • EasyBib
    • EndNote (tagged)
    • EndNote 8 (xml)
    • Medlars
    • Mendeley
    • Papers
    • RefWorks Tagged
    • Ref Manager
    • RIS
    • Zotero

     Request Permissions

    Share
    Indirect Evidence for the Efficacy of Methotrexate in Diffuse Systemic Sclerosis
    ANDREA H.L. LOW, PETER LEE
    The Journal of Rheumatology Nov 2008, 35 (11) 2286; DOI: 10.3899/jrheum.080492
    del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
    • Tweet Widget
    • Facebook Like
    • Google Plus One
    Save to my folders

    Jump to section

    • Article
    • References
    • Info & Metrics
    • PDF
    • eLetters

    Related Articles

    Cited By...

    More in this TOC Section

    • Drs. Dai and Felson reply
    • Drs. Carter and Do reply
    • Drs. Monsalve and Anaya reply
    Show more Correspondence

    Similar Articles

    Content

    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • COVID-19 and Rheumatology

    Resources

    • Guide for Authors
    • Submit Manuscript
    • Author Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies

    Subscribers

    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions

    More

    • About Us
    • Contact Us
    • My Alerts
    • My Folders
    • RSS Feeds
    The Journal of Rheumatology
    The content of this site is intended for health care professionals.
    Copyright © 2016 by The Journal of Rheumatology Publishing Co. Ltd.
    Print ISSN: 0315-162X; Online ISSN: 1499-2752
    Powered by HighWire